Oscient Pharmaceuticals News
Most Popular Oscient Pharmaceuticals Story
Telik, Oscient cut jobs and refocus efforts
Telik is joining the ranks of biotech survivalists. It's cutting 43 jobs and reorganizing its work to focus on its late-stage drug prospects. The 44 percent workforce reduction is eliminating jobs Read more...
Latest Headlines
- July 14, 2009
- March 25, 2009
- February 12, 2009
- September 12, 2006
- May 23, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
